Epidemiology of hepatocellular carcinoma.

Although rare in Canada and the United States, hepatocellular carcinoma (HCC) ranks as the eighth most common cancer in the world. High-risk regions are East and Southeast Asia, and sub-Saharan Africa. Independent of race and geography, rates in men are at least two to three times those in women; this sex ratio is more pronounced in high-risk regions. Rates of HCC in the United States have increased by 70% over the past two decades. Registry data in Canada and Western Europe show similar trends. In contrast, the incidence of HCC in Singapore and Shanghai, China, both high-risk regions, has declined steadily over the past two decades. Among white and black Americans, there is an inverse relationship between social class status and HCC incidence. Chronic infection by the hepatitis B virus (HBV) is by far the most important risk factor for HCC in humans. It is estimated that 80% of HCC worldwide is etiologically associated with HBV. In the United States, although the infection rate in the general population is low, HBV is estimated to account for one in four cases of HCC among non-Asians. Chronic infection by the hepatitis C virus is another important risk factor for HCC in the United States; however, this virus is believed to play a relatively minor role in the development of HCC in Africa and Asia. Dietary aflatoxin exposure is an important codeterminant of HCC risk in Africa and parts of Asia. In Canada and the United States, excessive alcohol intake, cigarette smoking and oral contraceptive use in women also are risk factors for HCC.

[1]  R. Cohen,et al.  Hepatocellular carcinoma in a woman on long‐term oral contraceptives , 1977, Cancer.

[2]  B. McMahon,et al.  Primary hepatocellular carcinoma in alaskan natives, 1969–1979 , 1981, International journal of cancer.

[3]  M. Kudo,et al.  Hepatocellular carcinomas infected with the novel TT DNA virus lack viral integration. , 1998, Biochemical and biophysical research communications.

[4]  R. Doll Cancers weakly related to smoking. , 1996, British medical bulletin.

[5]  P. Coursaget,et al.  Prevalence of hepatitis B and C viral markers in black and white patients with hepatocellular carcinoma in the United States. , 1990, Journal of the National Cancer Institute.

[6]  D. Forman,et al.  Oral contraceptives and hepatocellular carcinoma. , 1986, British medical journal.

[7]  M. Kedda,et al.  Does hepatitis GB virus‐C infection cause hepatocellular carcinoma in black Africans? , 1997, Hepatology.

[8]  M. Yu,et al.  Prospective evaluation of infection with hepatitis G virus in relation to hepatocellular carcinoma in Shanghai, China. , 2000, The Journal of infectious diseases.

[9]  G. A. Alexander,et al.  Racial/ethnic patterns of cancer in the United States, 1988-1992. , 1996 .

[10]  C. J. Chen,et al.  4-Aminobiphenyl DNA damage in liver tissue of hepatocellular carcinoma patients and controls. , 1998, American journal of epidemiology.

[11]  A. Sonnenberg,et al.  Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. , 1985, The New England journal of medicine.

[12]  T. Nishizawa,et al.  A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology. , 1997, Biochemical and biophysical research communications.

[13]  S. West,et al.  Seroepidemiology of hepatitis B virus in the Philippines. , 1986, American journal of epidemiology.

[14]  Tu Jt,et al.  Hepatitis B virus and primary liver cancer on Chongming Island, People's Republic of China. , 1985 .

[15]  F. X. Bosch,et al.  Risk factors for hepatocellular carcinoma in catalonia, spain , 1990, International journal of cancer.

[16]  R. Saracci,et al.  Time trends of primary liver cancer: indication of increased incidence in selected cancer registry populations. , 1980, Journal of the National Cancer Institute.

[17]  C. Linsell,et al.  Dietary aflatoxins and liver cancer--a population based study in Kenya. , 1973, British Journal of Cancer.

[18]  M. Yu,et al.  Presence of antibodies to the hepatitis B surface antigen is associated with an excess risk for hepatocellular carcinoma among non‐Asians in Los Angeles County, California , 1997 .

[19]  H. Adami,et al.  Excess risk of primary liver cancer in patients with diabetes mellitus. , 1996, Journal of the National Cancer Institute.

[20]  S. Shapiro,et al.  Oral contraceptive use and liver cancer. , 1989, American journal of epidemiology.

[21]  P. Majerus,et al.  Association of androgenic-anabolic steroid therapy with development of hepatocellular carcinoma. , 1972, Lancet.

[22]  I. Purchase,et al.  Hepatocellular carcinoma and dietary aflatoxin in Mozambique and Transkei. , 1985, British Journal of Cancer.

[23]  M. Kew,et al.  Contraceptive steroids as a risk factor for hepatocellular carcinoma: A case/control study in south african black women , 1990, Hepatology.

[24]  Lu-Yu Hwang,et al.  HEPATOCELLULAR CARCINOMA AND HEPATITIS B VIRUS A Prospective Study of 22 707 Men in Taiwan , 1981, The Lancet.

[25]  Keitaro Tanaka,et al.  Hepatitis B Virus, cigarette smoking and alcohol consumption in the development of hepatocellular carcinoma: A Case‐Control study in Fukuoka, Japan , 1992, International journal of cancer.

[26]  D. Parkin,et al.  Cholangiocarcinoma: epidemiology, mechanisms of carcinogenesis and prevention. , 1993, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[27]  B. Henderson,et al.  Hepatitis B virus and cigarette smoking: risk factors for hepatocellular carcinoma in Hong Kong. , 1982, Cancer research.

[28]  C. la Vecchia,et al.  Oral contraceptives and primary liver cancer. , 1989, British Journal of Cancer.

[29]  H. Kronenberg,et al.  ANDROGEN-INDUCED HEPATOMA , 1975, The Lancet.

[30]  K. Buetow,et al.  Susceptibility to hepatocellular carcinoma is associated with genetic variation in the enzymatic detoxification of aflatoxin B1. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[31]  G. Wogan Aflatoxins as risk factors for hepatocellular carcinoma in humans. , 1992, Cancer research.

[32]  J. Li,et al.  High incidence of hepatocellular carcinomas after synthetic estrogen administration in Syrian golden hamsters fed alpha-naphthoflavone: a new tumor model. , 1984, Journal of the National Cancer Institute.

[33]  B. Henderson,et al.  Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma , 1992, The Lancet.

[34]  H. El‐Serag,et al.  Rising incidence of hepatocellular carcinoma in the United States. , 1999, The New England journal of medicine.

[35]  W. Zheng,et al.  Cancer incidence trends in Urban Shanghai, 1972‐1989 , 1993, International journal of cancer.

[36]  B. Henderson,et al.  A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. , 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[37]  C. Wild,et al.  A preliminary survey on aflatoxin exposure in Singapore. , 1986, Annals of the Academy of Medicine, Singapore.

[38]  B. Macmahon,et al.  Smoking and hepatitis B-negative primary hepatocellular carcinoma. , 1980, Journal of the National Cancer Institute.

[39]  R. Wesley,et al.  The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease. , 1997, The New England journal of medicine.

[40]  M. Pike,et al.  Hepatitis, alcohol consumption, cigarette smoking, and hepatocellular carcinoma in Los Angeles. , 1983, Cancer research.

[41]  G. Mark,et al.  Multiple hepatic adenomas and a hepatocellular carcinoma in a man on oral methyl testosterone for eleven years , 1977, Cancer.

[42]  L. Mangiafico Contemporary American Immigrants: Patterns of Filipino, Korean, and Chinese Settlement in The United States , 1988 .

[43]  B. Portmann,et al.  Histological evidence of carcinoma in a hepatic tumour associated with oral contraceptives. , 1975, British medical journal.

[44]  H. Margolis,et al.  Molecular Cloning and Disease Association of Hepatitis G Virus: A Transfusion-Transmissible Agent , 1996, Science.

[45]  N. Day,et al.  Hepatitis B virus, tobacco smoking and ethanol consumption in the etiology of hepatocellular carcinoma , 1987, International journal of cancer.

[46]  T. Bothwell,et al.  IRON OVERLOAD IN BANTU SUBJECTS; STUDIES ON THE AVAILABILITY OF IRON IN BANTU BEER. , 1964, The American journal of clinical nutrition.

[47]  U. Gelatti,et al.  A case‐control study on GB virus C/hepatitis G virus infection and hepatocellular carcinoma. , 1997 .

[48]  B. Henderson,et al.  Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in southern Guangxi, China. , 1989, Cancer research.

[49]  K. Ishak,et al.  Epidemiology of hepatocellular adenoma. The role of oral contraceptive use. , 1979, JAMA.

[50]  J. Yager,et al.  Oral contraceptive steroids as promoters of hepatocarcinogenesis in female Sprague-Dawley rats. , 1980, Cancer research.

[51]  M. Kedda,et al.  Dietary iron overload as a risk factor for hepatocellular carcinoma in black africans , 1998, Hepatology.

[52]  B. Henderson,et al.  Low prevalence of hepatitis C infection in hepatocellular carcinoma (HCC) cases and population controls in Guangxi, a hyperendemic region for HCC in the People's Republic of China. , 1996, British Journal of Cancer.

[53]  H. Margolis,et al.  The Changing Epidemiology of Hepatitis B in the United States: Need for Alternative Vaccination Strategies , 1990 .

[54]  M Linet,et al.  Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. , 1997, Journal of the National Cancer Institute.

[55]  P. Tangkijvanich,et al.  Association of hepatitis viruses with hepatocellular carcinoma in Thailand , 1999, Journal of Gastroenterology.

[56]  Mimi C. Yu,et al.  Chronic infection with hepatitis G virus in relation to hepatocellular carcinoma among non‐Asians in Los Angeles County, California , 1999, Cancer.

[57]  K. Chia,et al.  Cervical cancer: trends in incidence and mortality in Singapore 1968 to 1987. , 1992, Annals of the Academy of Medicine, Singapore.

[58]  B. Henderson,et al.  Liver-cell adenomas associated with use of oral contraceptives. , 1976, The New England journal of medicine.

[59]  H. Ip,et al.  TRANSMISSION OF HEPATITIS B ANTIGENS FROM SYMPTOM FREE CARRIER MOTHERS TO THE FETUS AND THE INFANT , 1980, British journal of obstetrics and gynaecology.

[60]  K. Masuko,et al.  Infection with hepatitis GB virus C in patients on maintenance hemodialysis. , 1996, The New England journal of medicine.

[61]  D M Parkin,et al.  Estimates of the worldwide frequency of sixteen major cancers in 1980 , 1988, International journal of cancer.

[62]  J. Ferlay,et al.  Cancer incidence in Thailand, 1988-1991. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[63]  B. Henderson,et al.  Nonviral risk factors for hepatocellular carcinoma in a low-risk population, the non-Asians of Los Angeles County, California. , 1991, Journal of the National Cancer Institute.

[64]  L W Wang,et al.  Chronic hepatitis B carriers with null genotypes of glutathione S-transferase M1 and T1 polymorphisms who are exposed to aflatoxin are at increased risk of hepatocellular carcinoma. , 1996, American journal of human genetics.

[65]  F. Collins,et al.  Hereditary hemochromatosis: gene discovery and its implications for population-based screening. , 1998, JAMA.

[66]  D. Forman,et al.  Cancer of the liver and the use of oral contraceptives. , 1986, British medical journal.

[67]  B. Henderson,et al.  A cohort study of serum testosterone and hepatocellular carcinoma in Shanghai, China , 1995, International journal of cancer.

[68]  T. Kuroki,et al.  Poor association of GBV-C viremia with hepatocellular carcinoma. , 1997, Journal of hepatology.

[69]  H. Gurtoo,et al.  Effect of sex difference on the in vitro and in vivo metabolism of aflatoxin B1 by the rat. , 1976, Cancer research.